The University of Miami Leonard M. Miller School of Medicine is the graduate medical school of the University of Miami. Founded in 1952, it is the oldest medical school in the state of Florida.

During the past decade, University of Miami Miller School of Medicine conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 99 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 49 clinical trials were completed. i.e. 119.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Miller School of Medicine" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 68 trials, followed by "University of Miami" with 52 trials sponsored, "University of North Carolina, Chapel Hill" with 18 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 12 trials sponsored and "Bristol-Myers Squibb" with 12 trials sponsored. Other sponsors include 300 different institutions and companies that sponsored additional 186 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Miller School of Medicine" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 21 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 17 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 8 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator. Other collaborators include 235 different institutions and companies that were collaborators in the rest 171 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Miller School of Medicine" are "HIV Infections" (128 trials), "Cystic Fibrosis" (14 trials), "HIV" (13 trials), "Amyotrophic Lateral Sclerosis" (11 trials) and "Asthma" (7 trials). Many other conditions were trialed in "University of Miami Miller School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Miami Miller School of Medicine" are "Drug" (317 trials), "Other" (42 trials), "Behavioral" (31 trials), "Biological" (31 trials) and "Device" (29 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (79 trials), "Zidovudine" (36 trials), "Lamivudine" (24 trials), "Indinavir sulfate" (19 trials) and "Didanosine" (14 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Miller School of Medicine" are 434 trials for "All" genders, 18 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "University of Miami Miller School of Medicine". undefined are not yet recruiting, 29 are recruiting, 26 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 332 completed trials in University of Miami Miller School of Medicine, 2 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Miller School of Medicine, 58 "Phase 1" clinical trials were conducted, 154 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 71 trials that are defined as “Not Applicable".